We all know rehab is not accessible to everyone who needs it after a neurologic injury. There are a number of reasons why, and, fortunately, there are also people looking to solve that problem. On today's show we interviewed Amy Rohe, MS, OTR/L, CSRS, ATP who works for Neurofenix, a company that is transforming neurological rehabilitation with its innovative virtual therapy platform. The primary tool used by the OTs of Neurofenix is the NeuroBall, an FDA-approved device, that offers patients engaging, data-driven occupational therapy from the comfort of their homes.

This model of delivery is really unique and interesting for clinicians and innovators in the healthcare space! The approach addresses critical gaps in traditional rehabilitation by providing accessible, consistent therapy for patients with neurological conditions, particularly stroke survivors. With over 90% patient adherence and plans for expansion, Neurofenix represents the future of technology-driven rehabilitation.

Learn more about Neurofenix at https://www.neurofenix.com/

www.linkedin.com/company/neurofenix

IG @neurofenix

Reach out at: [email protected]